Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rafael González‐Fernández
Observed names:
R. Gonzalez-Fernández,
Rafael Gonzalez-Fernandez,
Rafael González-Fernández
Institutions:
Instituto Maimónides de Investigación Biomédica de Córdoba,
Hospital Universitario Reina Sofía,
University of Córdoba
Observed institutions:
Instituto Maimónides de Investigación Biomédica de Córdoba,
Hospital Universitario Reina Sofía,
University of Córdoba
ORCID:
0000-0002-9406-558X
Observed ORCID:
0000-0002-9406-558X
OpenAlex ID:
A5109357437
High-resolution characterization of allelic and haplotypic HLA frequency distribution in a Spanish population using high-throughput next-generation sequencing
2019
·
Gonzalo Montero-Martín
, Kalyan C. Mallempati
, et al.
·
Human Immunology
·
39
PDF
Report from the Killer-cell Immunoglobulin-like Receptors (KIR) component of the 17th International HLA and Immunogenetics Workshop
2018
·
Maneesh K. Misra
, Danillo G. Augusto
, et al.
·
Human Immunology
·
22
PDF
KIR Genes and Their Ligands Predict the Response to Anti-EGFR Monoclonal Antibodies in Solid Tumors
2016
·
Cristina Morales-Estevez
, Juan De la Haba-Rodriguez
, et al.
·
Frontiers in Immunology
·
13
Metabolic shift underlies tumor progression and immune evasion in S‐nitrosoglutathione reductase‐deficient cancer
2023
·
Rafael Mena‐Osuna
, Ana Mantrana
, et al.
·
The Journal of Pathology
·
8
Glycolysis Inhibition Restores Immune Sensitivity in GSNOR–Deficient Colorectal Cancer
2025
·
Ana Mantrana
, María Teresa Sánchez-Montero
, et al.
·
Laboratory Investigation
·
4
Imbalanced NK cell subpopulations and TIGIT expression limit cetuximab efficacy in colorectal cancer: A promising target for treatment enhancement
2025
·
Carmen Navarrete‐Sirvent
, Ana Mantrana
, et al.
·
Clinical and Translational Medicine
·
3
PDF
Proteomic and immunophenotypic signatures reveal immune-mediated resistance to cetuximab in metastatic colorectal cancer
2026
·
Carmen Navarrete Sirvent
, Aurora Rivas-Crespo
, et al.
PDF
EP.06.66 Prediction of Immune-Related Adverse Events by Human Leukocyte Antigen (HLA) and Other Biomarkers in Patients With Non-Small Cell Lung Cancer
2025
·
P. Flores-Paco
, L. Pérez-Bartivas
, et al.
·
Journal of Thoracic Oncology
Immune Modulation Through KIR–HLA Interactions Influences Cetuximab Efficacy in Colorectal Cancer
2025
·
María Gómez-Aguilera
, Bárbara Manzanares-Martín
, et al.
·
International Journal of Molecular Sciences
PDF
Killer-cell Inmunoglobulin-like Receptor (KIR) genes as a predictor of response to the anti-HER therapy in solid tumors.
2016
·
Cristina Morales-Estevez
, Barbara Manzanares-Martin
, et al.
·
Journal of Clinical Oncology
Analysis of the HLA-I genotypes in patients with solid tumours who were treated with anti-HER therapy.
2016
·
Javier López-González
, Cristina Morales-Estevez
, et al.
·
Journal of Clinical Oncology
Association of Killer cell immunoglobulin-like receptors (KIRs) polymorphisms and advanced cancer in a Caucasian population.
2015
·
Cristina Morales-Estevez
, Barbara Manzanares-Martin
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
12
Citation count:
89
H-index:
4
I10-index:
3
Year
Topic
Type